0.06
+0.0015(+2.70%)
Currency In USD
Address
399 Binney Street
Cambridge, MA 02139
United States of America
Phone
617 679 9600
Website
Sector
Healthcare
Industry
Biotechnology
Employees
6
First IPO Date
July 18, 2018
| Name | Title | Pay | Year Born |
| Craig R. Jalbert | President, Treasurer, CS, Principal Exe Officer, Interim Principal Fin. & Acc. Off. and Director | 0 | 1962 |
| Marissa Hanify | Director of Corporation Communications | 0 | N/A |
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.